Revisión

Nonalcoholic fatty liver disease (nafld) pathophysiology in obese children and adolescents: update

Silvana Neves Ferraz De Assunção, Ney Christian Boa Sorte, Crésio Dantas Alves, Patricia S. Almeida Mendes, Carlos Roberto Brites Alves, Luciana Rodrigues Silva

VOLUMEN 34, NÚM. 3, mayo-junio (2017), PAG. 727-730

Logo Descargas Número de descargas: 10037 Logo Visitas Número de visitas: 9729 Citas Citas: 7

Compártelo:

Objective: Although the nonalcoholic fatty liver disease was first identified in 1980, it presents multifactorial and unclear pathophysiology. In this review, we intend to update the pathophysiological mechanisms of a high morbidity and mortality associated disease that is affecting obese children worldwide.Data sources: The PubMed and the Cochrane Library databases were used in the search strategy for articles related to nonalcoholic fatty liver disease and published in the last three decades.Data summary: This review describes the current knowledge on the different mechanisms related to the pathophysiology of nonalcoholic fatty liver disease focused on histological, anatomical and biochemical aspects involved in triggering steatohepatitis and leading to cirrhosis.Conclusions: The clinical research and advanced technological resources demonstrated several determinants pathophysiological mechanisms of nonalcoholic fatty liver disease trying to assist in their treatment and change its natural course.

Palabras Clave: Non-alcoholic fatty liver disease. Fatty liver. Obesity.

Descargar PDF (ENGLISH)

Citas
Bibliografía

Chen, Bo, Zheng, Yang-Min, Zhang, Miao-Qing, Han, Ying, Zhang, Jing-Pu, Hu, Chang-Qin (2020) Microarray Expression Profiling and Raman Spectroscopy Reveal Anti-Fatty Liver Action of Berberine in a Diet-Induced Larval Zebrafish Model. Frontiers in Pharmacology

Chen, Bo, Zheng, Yang-Min, Zhang, Jing-Pu (2018) Comparative Study of Different Diets-Induced NAFLD Models of Zebrafish. Frontiers in Endocrinology

Barretto, Junaura R., Boa-Sorte, Ney, Vinhaes, Caian L., Malta-Santos, Hayna, Rebouças-Silva, Jessica, Ramos, Camila F., Torres-Nascimento, Monica A. S., Borges, Valeria M., Andrade, Bruno B. (2020) Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study. Nutrients

Fan, Hongqiong, Liu, Shanshan, Jiao, Benzheng, Liang, Xinyue (2023) Low‑dose ionizing radiation attenuates high glucose‑induced hepatic apoptosis and immune factor release via modulation of a miR‑155‑SOCS1 axis. Molecular Medicine Reports

Huang, Ru‐Lai, Li, Chung‐Hao, Du, Ye‐Fong, Cheng, Kai‐Pi, Lin, Ching‐Han, Hu, Che‐Yuan, Wu, Jin Shang, Chang, Chih‐Jen, Wu, Hung‐Tsung, Ou, Horng‐Yih (2020) Discovery of a role of the novel hepatokine, hepassocin, in obesity. BioFactors

Song, Shih‐Hsi, Wong, Ying‐Chi, Wu, Tzee‐Chung, Huang, Ching‐Feng (2021) Pediatric non‐alcoholic fatty liver disease predicted by anthropometric values through transient elastography. Pediatrics International

Lin, Xinyue, Zhang, Juanhong, Chu, Yajun, Nie, Qiuying, Zhang, Junmin (2024) Berberine prevents NAFLD and HCC by modulating metabolic disorders. Pharmacology & Therapeutics

Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 1980; 55: 434-438

Lewis JR, Mohanty SR. Nonalcoholic fatty liver disease: a review and update. Dig Dis Sci 2010; 55: 560-78.
DOI: 10.1007/s10620-009-1081-0

Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30: 1356–1362

Kemmer, N, Neff, GW, Franco, E, et al, 2013. Nonalcoholic fatty liver disease epidemic and its implications for liver transplantation. Transplantation 96 (10), 860-862.

Younossi ZM, Stepanova M, Afendy M, Fang Y, Younossi Y, Mir H, et al. Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clinical Gastroenterology and Hepatology. 2011; 9(6):524–30.
DOI: 10.1016/j.cgh.2011.03.020

Padilha PC, Rocha HF, Alves N, Peres WA. Prevalence of nonalcoholic fatty liver disease in obese children and adolescents: a systematic review. Rev Paul Pediatr 2010; 28:387-93.
DOI: 10.1590/S0103-05822010000400016

Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P. The natural history of nonalcoholic fatty liver disease in children: a follow-up study for up to 20-years. Gut 2009; 58:1538-44.
DOI: 10.1136/gut.2008.171280

Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics 2006; 118: 1388-1393.
DOI: 10.1542/peds.2006-1212

Moyer VA, Klein JD, Ockene JK, Teutsch SM, Johnson MS, Allan JD, Childhood Obesity Working Group, US Preventive Services Task Force. Screening foroverweight in children and adolescents: where is the evidence? a commentary by the childhood obesity working group of the US Preventive Services Task Force. Pediatrics 2005; 116: 235-8.
DOI: 10.1542/peds.2005-0305

Elariny HA, Baranova A. Comment on: Diet-induced obesity associated with steatosis, oxidative stress and inflammation in liver. Surg Obes Relat Dis 2012, 8(1): 81-3.

Tilg H, Moschen AR. Evolving therapies for non-alcoholic steatohepatitis. Expert Opin Drug Discov 2014; 9: 687-696.
DOI: 10.1517/17460441.2014.911283

Moschen AR, Kaser S, Tilg H. Non-alcoholic steatohepatitis: a microbiota-driven disease. Trends Endocrinol Metab 2013; 24: 537-545.
DOI: 10.1016/j.tem.2013.05.009

Caprio S. Definitions and pathophysiology of the metabolic syndrome in obese children and adolescents. Int J Obes (lond) 2005; 29 (Suppl) 2):S24-S25.

Louthan MV, Theriot JA, Zimmerman E, Stutts JT, McClain CJ. Decreased prevalence or nonalcoholic fatty liver disease in black obese children. J Pediatr Gastroenterol Nutr 2005; 41: 426-429.
DOI: 10.1097/01.mpg.0000177314.65824.4d

Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 346:1221–1231.
DOI: 10.1056/NEJMra011775

Zachary D. Goodman. The Impact of Obesity on Liver Histology. Clin Liver Dis 18 (2014) 33-40.

Freitas LAR, Cotrim HP. Esteato-hepatite não alcoólica. Atlas histológico 2006; 68 pg.

Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012; 54:700–713.
DOI: 10.1097/MPG.0b013e318252a13f

Falck-Ytter Y, Younossi ZM, Marchesini G, McCullough AJ. Clinical features and natural history of nonalcoholic steatosis syndromes. Sem Liver Dis. 2001; 21: 17-26.
DOI: 10.1055/s-2001-12926

Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003; 37: 1202-1219.
DOI: 10.1053/jhep.2003.50193

Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest. 2004; 114:147-152.
DOI: 10.1172/JCI200422422

Neuschwander-Tetri BA. Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: the central role of nontriglyceride fatty acid metabolites. Hepatology 2010; 52:774-788.
DOI: 10.1002/hep.23719

Westerbacka J, Lammi K, Hakkinen AM, Rissanen A, Salminen I, Aro A, et al. Dietary fat conten modifies liver fat in overweight nondiabetic subjects. J Clin Endocrinol Metab 2005; 90: 2804-2809.
DOI: 10.1210/jc.2004-1983

Louthan MV, Barve S, McClain CJ, Joshi-Barve S. Decreased serum adiponectin: an early event in pediatric nonalcoholic fatty liver disease. J Pediatr 2005; 147:835-838.
DOI: 10.1016/j.jpeds.2005.07.030

Molnar D, Decsi T, Koletzko B. Reduced antioxidante status in obese children with multimetabolic syndrome. Int J Obes Relat Metab Disord 2004; 28:1197-2658.
DOI: 10.1038/sj.ijo.0802719

Chassaing B, Etienne‐Mesmin L, Gewirtz AT. Microbiota‐liver axis in hepatic disease. Hepatology. 2014; 59(1):328–39.
DOI: 10.1002/hep.26494

Dawson PA, Karpen SJ. Intestinal transport and metabolism of bile acids. Journal of lipid research. 2015; 56(6):1085–99.
DOI: 10.1194/jlr.R054114

Hylemon PB, Zhou H, Pandak WM, Ren S, Gil G, Dent P. Bile acids as regulatory molecules. J Lipid Res. 2009; 50(8):1509–20.
DOI: 10.1194/jlr.R900007-JLR200

Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012; 148(6):1258–70.
DOI: 10.1016/j.cell.2012.01.035

Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, Fischer SE, et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease. Hepatology. 2013;58 (1):120–7.
DOI: 10.1002/hep.26319

Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes (Lond). 2008; 32(11):1720–4.
DOI: 10.1038/ijo.2008.155

Scaglioni S, Verduci E, Salvioni M, Biondi ML, Radaelli G, Agostoni C, et al. PPAR-γPro12Ala variant, insulin resistance and plasma long chain polyunsaturated fatty acids en childhood obesity. Pediatr Res 2006; 60:485-489.
DOI: 10.1203/01.pdr.0000238259.41560.00

Ciesck S, Hadem J, Fischer J, Manns MP, Strassburg CP. A rare cause of nonalcoholic fatty liver disease. Ann Intern Med 2006; 154-155.

Schwimmer JB, McGreal N, Deutsch R, Finegold MJ, Lavine JE. Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics 2005; 115:e561-e565.